|
Jul 24
|
Fibroblast Growth Factors (FGFs) Global Market Report 2025-2029 & 2034 | Regenerative Medicine Demand and Biotech Advancements Fueling Expansion
|
|
Jul 24
|
How Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?
|
|
Jul 24
|
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Jul 24
|
Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPS
|
|
Jul 24
|
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
|
|
Jul 24
|
Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL
|
|
Jul 24
|
Looking For Yields: Merck, Hormel Foods, And Spire Are Consistent Moneymakers
|
|
Jul 24
|
Mountain Valley MD Holdings Announces Changes to Board of Directors
|
|
Jul 23
|
Abivax Hits The Stratosphere, Up Nearly 600%, On 'Potentially Disruptive' Results
|
|
Jul 23
|
Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?
|
|
Jul 2
|
Merck's HPV Vaccine Gardasil Remains Key Driver Ahead of Q2 Results, UBS Says
|
|
Jul 2
|
Merck (NYSE:MRK) Gains FDA Priority Review For WINREVAIR PAH Treatment sBLA
|
|
Jul 2
|
What's Fueling Tempus AI's Explosive Sales Growth?
|
|
Jul 2
|
Merck concludes SpringWorks acquisition for $3.4bn
|
|
Jul 2
|
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
|
|
Jul 2
|
Can China sustain a surge in oncology drug innovation?
|
|
Jul 2
|
Summit Therapeutics (SMMT) Rated Buy on Ivonescimab’s Cancer-Fighting Potential
|
|
Jul 1
|
Trading Rotation Kicks Off 2nd Half of 2025
|
|
Jul 1
|
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?
|
|
Jul 1
|
Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth
|